Literature DB >> 16219906

Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala.

Shiu-Hwa Yeh1, Sheng-Chun Mao, Hui-Ching Lin, Po-Wu Gean.   

Abstract

Fear conditioning has been ascribed to presynaptic mechanisms, particularly presynaptic facilitation of transmission at thalamo- and cortico-amygdala synapses. Here, by labeling surface receptors with biotin or using membrane fractionation approaches, we report that fear conditioning resulted in an increase in surface expression of GluR1 subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in the amygdala, whereas total GluR1 mRNA and protein levels were unchanged. The control group that received conditioned stimulus (CS) and unconditioned stimulus in an unpaired fashion did not present any increase, indicating that GluR1 increase was specific to the learning component of the task. Conditioning-induced increase in surface expression of GluR1 depended on the activation of N-methyl-d-aspartate receptors and protein kinases and required the synthesis of new proteins. CS-alone trials applied 24 h before training attenuated fear-potentiated startle and prevented conditioning-induced increase in surface expression of GluR1. Increase in GluR1 was also observed in the amygdala slices after delivery of tetanic stimulation that elicited long-term potentiation of synaptic transmission. Proteasome inhibitor increased surface expression of GluR1 in a time- and dose-dependent manner. Furthermore, pretraining administration of proteasome inhibitor into the amygdala facilitated the fear-potentiated startle. These results suggest that long-term memory formation is correlated with the change in synaptic expression of GluR1, and trafficking of GluR1 to the synaptic sites contributes at least in part to the expression of fear memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219906     DOI: 10.1124/mol.105.017194

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  49 in total

1.  Postsynaptic BDNF signalling regulates long-term potentiation at thalamo-amygdala afferents.

Authors:  S Meis; T Endres; V Lessmann
Journal:  J Physiol       Date:  2011-11-14       Impact factor: 5.182

Review 2.  Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.

Authors:  Hans-Christian Pape; Denis Pare
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

Review 3.  AMPA receptor trafficking and learning.

Authors:  J Keifer; Z Zheng
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

Review 4.  Protein degradation and memory formation.

Authors:  Diasynou Fioravante; John H Byrne
Journal:  Brain Res Bull       Date:  2010-11-13       Impact factor: 4.077

5.  Dynamics of Hippocampal Protein Expression During Long-term Spatial Memory Formation.

Authors:  Natalia Borovok; Elimelech Nesher; Yishai Levin; Michal Reichenstein; Albert Pinhasov; Izhak Michaelevski
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

6.  Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace.

Authors:  Sheng-Chun Mao; Ya-Hsin Hsiao; Po-Wu Gean
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

7.  Amygdala depotentiation and fear extinction.

Authors:  Jeongyeon Kim; Sukwon Lee; Kyungjoon Park; Ingie Hong; Beomjong Song; Gihoon Son; Heewoo Park; Woon Ryoung Kim; Eunjin Park; Han Kyung Choe; Hyun Kim; Changjoong Lee; Woong Sun; Kyungjin Kim; Ki Soon Shin; Sukwoo Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-26       Impact factor: 11.205

Review 8.  Synaptic AMPA receptor plasticity and behavior.

Authors:  Helmut W Kessels; Roberto Malinow
Journal:  Neuron       Date:  2009-02-12       Impact factor: 17.173

9.  Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

Authors:  M L Woolley; K A Waters; J E Gartlon; L P Lacroix; C Jennings; F Shaughnessy; A Ong; D J Pemberton; M H Harries; E Southam; D N C Jones; L A Dawson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

10.  Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.

Authors:  Xiaochuan Guo; Peter J Hamilton; Nicholas J Reish; J David Sweatt; Courtney A Miller; Gavin Rumbaugh
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.